Oral fidaxomicin versus vancomycin for the treatment of Clostridioides difficile infection: A systematic review and meta-analysis of randomized controlled trials

Author:

Tashiro Sho,Mihara Takayuki,Sasaki Moe,Shimamura Chiaki,Shimamura Rina,Suzuki Shiho,Yoshikawa Maiko,Hasegawa Tatsuki,Enoki YukiORCID,Taguchi Kazuaki,Matsumoto KazuakiORCID,Ohge Hiroki,Suzuki HiromichiORCID,Nakamura AtsushiORCID,Mori Nobuaki,Morinaga Yoshitomo,Yamagishi Yuka,Yoshizawa Sadako,Yanagihara Katsunori,Mikamo Hiroshige,Kunishima Hiroyuki

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference51 articles.

1. One health approach to Clostridioides difficile in Japan;Usui;J Infect Chemother,2020

2. Clostridium difficile infection and antibiotic-associated diarrhoea;Mullish;Clin Med J R Coll Physicians London,2018

3. Antibiotic resistance threats in the United States, 2019,2019

4. Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review;Thomas;J Antimicrob Chemother,2003

5. Community-associated clostridium difficile infection antibiotics: a meta-analysis;Deshpande;J Antimicrob Chemother,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3